Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

1

Avatar Charl9s (70.45) Submitted: 8/20/06 11:46 AM : Outperform Start Price: $16.26 ALKS Score: -5.34

Company is testing new delivery system for drugs.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links